DIGICELL
LIVE

Serial Number

79331034

Owner

Bit Bio Limited

Attorney

Katrina G. Hull

Filing Date

Sep 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

DIGICELL Trademark

Serial Number: 79331034 • Registration: 6982561

DIGICELL is a trademark filed by Bit Bio Limited on September 8, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

Bit Bio Limited (21 trademarks)

Pioneer House,
Cambridge, Cambridgeshire CB24 9NL , GB

Entity Type: 99

Trademark Details

Filing Date

September 8, 2021

Registration Date

February 21, 2023

Published for Opposition

December 6, 2022

Goods & Services

Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and to control laboratory manufacturing robots; bioreactors for biomanufacturing; bioreactors for research use; bioreactor for cell culturing; bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory automation equipment; electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory automation equipment; laboratory apparatus for magnetic cell separation

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, stem cells for scientific purposes, stem cells other than for medical or veterinary purposes, skeletal myocytes for research purposes, cortical neurons for research purposes, biological tissue for research and scientific purposes, biological tissue cultures other than for medical or veterinary purposes, cultures of cell media other than for medical or veterinary use, chemical reagents for use in biotechnology, other than for medical or veterinary use, nutritive agents for processing living cells other than for medical use, semi-processed natural proteins for manufacturing food, proteins for use in the manufacture of food products, proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, living cells for medical use, cells for medical use, biological preparations for medical use, diagnostic preparations for medical and/or veterinary purposes, cell preparations for drug screening, cell preparations for genetic testing, screening, stem cells for medical purposes, stem cells for veterinary purposes, cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, cell separation reagents, magnetic cell separation equipment, dietary supplements, protein supplements, nutrition supplements, meat, meat substitutes, tissue engineered meat, synthetic meat, cultured meat, laboratory-grown meat and fish, not live

Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; genetically or otherwise modified cells for medical, therapeutic or clinical use; cells which are propagated, cultivated and expanded in bioreactors for medical, therapeutic or clinical use; cells for the purpose of tissue regeneration for medical or clinical use; living cells for medical use; cells for medical use; diagnostic preparations for medical and veterinary purposes; cell preparations for medical use for drug screening; cell preparations for genetic testing, screening for medical purposes or clinical use; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical, diagnostic or clinical use; tissue culture media, growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells for medical, therapeutic or clinical use; cell separation reagents for medical, therapeutic or clinical use; dietary supplements; protein supplements; nutrition supplements

Meat; meat substitutes; tissue engineered meat; synthetic meat; cultured meat; laboratory-grown meat; fish, not live

Biotechnology research; biotechnology testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; stem cell research; synthetic biology services, namely, biological research; stem cell biology services, namely, biological research; scientific research, laboratory, development and consulting services for scientific, research, clinical, medical, and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; research and development in the field of microorganisms and cells; research and development in relation to genetic testing and screening; research and development in relation to drug screening; cell separation technology services, namely, research of technology in the field of cell separation for scientific, research, clinical, medical, and manufacturing purposes; cell separation research services; consultancy relating to biotechnology; consultancy relating to drug screening; scientific and research consultancy relating to genetic screening; scientific and research consultancy relating to cell therapy; laboratory research in the field of drug discovery; research on food; research and development in the field of animal cells cultivated within bioreactors; research in the reduction of carbon emissions; development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposes

Stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; biological human tissue for research and scientific purposes; biological tissue cultures other than for medical or veterinary purposes; cultures of cell media for scientific and research use, not for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products; proteins for use in recombinant DNA technology other than for medical use; cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical research use

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 8, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Feb 14, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 8, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 24, 2023 FICS
FINAL DISPOSITION PROCESSED
May 24, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 21, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 21, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 21, 2023 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Jan 20, 2023 CHPB
ASSIGNED TO PETITION STAFF
Jan 17, 2023 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 21, 2022 EPPA
NOTIFICATION PROCESSED BY IB
Dec 13, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 6, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 3, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 3, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 3, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 3, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 2, 2022 ZZZX
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 28, 2022 CORN
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 11, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 23, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 23, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 23, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 23, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2022 TROA
REFUSAL PROCESSED BY IB
Jul 26, 2022 RFNT
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 23, 2022 CRCV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 29, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jun 29, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 24, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 23, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 13, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 18, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 13, 2022 REPR